The global Swine Influenza Vaccines market size was valued at US$ 121.3 million in 2023. With growing demand in downstream market, the Swine Influenza Vaccines is forecast to a readjusted size of US$ 164.6 million by 2030 with a CAGR of 4.5% during review period.
The research report highlights the growth potential of the global Swine Influenza Vaccines market. Swine Influenza Vaccines are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Swine Influenza Vaccines. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Swine Influenza Vaccines market.
Vaccines have been developed to protect against the virus that causes swine flu. There are two different brands of vaccine – Pandemrix and Celvapan.
The swine influenza vaccines market is experiencing significant growth due to the increasing prevalence of swine influenza and the rising demand for efficient disease prevention in swine populations. Swine influenza vaccines play a vital role in controlling and preventing respiratory diseases in pigs. The market is driven by factors such as the growth of the swine industry, the need for improved animal health and welfare, and the implementation of strict biosecurity measures. Advancements in vaccine development, including the availability of more effective and targeted vaccines, are further contributing to market growth. However, challenges such as the emergence of new strains of swine influenza virus and the requirement for periodic vaccine updates may impact market expansion. With the continuous focus on swine health management, disease prevention, and sustainable swine production, the swine influenza vaccines market is expected to witness sustained growth in the coming years.
Key Features:
The report on Swine Influenza Vaccines market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Swine Influenza Vaccines market. It may include historical data, market segmentation by Type (e.g., Live Vaccines, Killed Vaccines), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Swine Influenza Vaccines market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Swine Influenza Vaccines market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Swine Influenza Vaccines industry. This include advancements in Swine Influenza Vaccines technology, Swine Influenza Vaccines new entrants, Swine Influenza Vaccines new investment, and other innovations that are shaping the future of Swine Influenza Vaccines.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Swine Influenza Vaccines market. It includes factors influencing customer ' purchasing decisions, preferences for Swine Influenza Vaccines product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Swine Influenza Vaccines market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Swine Influenza Vaccines market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Swine Influenza Vaccines market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Swine Influenza Vaccines industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Swine Influenza Vaccines market.
Market Segmentation:
Swine Influenza Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Live Vaccines
Killed Vaccines
Segmentation by application
Commodity Pig
Breeding Pig
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Chengdu TECBOND
Green Cross Veterinary
Hipra
MSD Animal Health (Merck)
Zoetis
CAHIC
Boehringer Ingelheim
Ceva
Ringpu Biology
DHN
Key Questions Addressed in this Report
What is the 10-year outlook for the global Swine Influenza Vaccines market?
What factors are driving Swine Influenza Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Swine Influenza Vaccines market opportunities vary by end market size?
How does Swine Influenza Vaccines break out type, application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Swine Influenza Vaccines Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Swine Influenza Vaccines by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Swine Influenza Vaccines by Country/Region, 2019, 2023 & 2030
2.2 Swine Influenza Vaccines Segment by Type
2.2.1 Live Vaccines
2.2.2 Killed Vaccines
2.3 Swine Influenza Vaccines Sales by Type
2.3.1 Global Swine Influenza Vaccines Sales Market Share by Type (2019-2024)
2.3.2 Global Swine Influenza Vaccines Revenue and Market Share by Type (2019-2024)
2.3.3 Global Swine Influenza Vaccines Sale Price by Type (2019-2024)
2.4 Swine Influenza Vaccines Segment by Application
2.4.1 Commodity Pig
2.4.2 Breeding Pig
2.5 Swine Influenza Vaccines Sales by Application
2.5.1 Global Swine Influenza Vaccines Sale Market Share by Application (2019-2024)
2.5.2 Global Swine Influenza Vaccines Revenue and Market Share by Application (2019-2024)
2.5.3 Global Swine Influenza Vaccines Sale Price by Application (2019-2024)
3 Global Swine Influenza Vaccines by Company
3.1 Global Swine Influenza Vaccines Breakdown Data by Company
3.1.1 Global Swine Influenza Vaccines Annual Sales by Company (2019-2024)
3.1.2 Global Swine Influenza Vaccines Sales Market Share by Company (2019-2024)
3.2 Global Swine Influenza Vaccines Annual Revenue by Company (2019-2024)
3.2.1 Global Swine Influenza Vaccines Revenue by Company (2019-2024)
3.2.2 Global Swine Influenza Vaccines Revenue Market Share by Company (2019-2024)
3.3 Global Swine Influenza Vaccines Sale Price by Company
3.4 Key Manufacturers Swine Influenza Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Swine Influenza Vaccines Product Location Distribution
3.4.2 Players Swine Influenza Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Swine Influenza Vaccines by Geographic Region
4.1 World Historic Swine Influenza Vaccines Market Size by Geographic Region (2019-2024)
4.1.1 Global Swine Influenza Vaccines Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Swine Influenza Vaccines Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Swine Influenza Vaccines Market Size by Country/Region (2019-2024)
4.2.1 Global Swine Influenza Vaccines Annual Sales by Country/Region (2019-2024)
4.2.2 Global Swine Influenza Vaccines Annual Revenue by Country/Region (2019-2024)
4.3 Americas Swine Influenza Vaccines Sales Growth
4.4 APAC Swine Influenza Vaccines Sales Growth
4.5 Europe Swine Influenza Vaccines Sales Growth
4.6 Middle East & Africa Swine Influenza Vaccines Sales Growth
5 Americas
5.1 Americas Swine Influenza Vaccines Sales by Country
5.1.1 Americas Swine Influenza Vaccines Sales by Country (2019-2024)
5.1.2 Americas Swine Influenza Vaccines Revenue by Country (2019-2024)
5.2 Americas Swine Influenza Vaccines Sales by Type
5.3 Americas Swine Influenza Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Swine Influenza Vaccines Sales by Region
6.1.1 APAC Swine Influenza Vaccines Sales by Region (2019-2024)
6.1.2 APAC Swine Influenza Vaccines Revenue by Region (2019-2024)
6.2 APAC Swine Influenza Vaccines Sales by Type
6.3 APAC Swine Influenza Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Swine Influenza Vaccines by Country
7.1.1 Europe Swine Influenza Vaccines Sales by Country (2019-2024)
7.1.2 Europe Swine Influenza Vaccines Revenue by Country (2019-2024)
7.2 Europe Swine Influenza Vaccines Sales by Type
7.3 Europe Swine Influenza Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Swine Influenza Vaccines by Country
8.1.1 Middle East & Africa Swine Influenza Vaccines Sales by Country (2019-2024)
8.1.2 Middle East & Africa Swine Influenza Vaccines Revenue by Country (2019-2024)
8.2 Middle East & Africa Swine Influenza Vaccines Sales by Type
8.3 Middle East & Africa Swine Influenza Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Swine Influenza Vaccines
10.3 Manufacturing Process Analysis of Swine Influenza Vaccines
10.4 Industry Chain Structure of Swine Influenza Vaccines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Swine Influenza Vaccines Distributors
11.3 Swine Influenza Vaccines Customer
12 World Forecast Review for Swine Influenza Vaccines by Geographic Region
12.1 Global Swine Influenza Vaccines Market Size Forecast by Region
12.1.1 Global Swine Influenza Vaccines Forecast by Region (2025-2030)
12.1.2 Global Swine Influenza Vaccines Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Swine Influenza Vaccines Forecast by Type
12.7 Global Swine Influenza Vaccines Forecast by Application
13 Key Players Analysis
13.1 Chengdu TECBOND
13.1.1 Chengdu TECBOND Company Information
13.1.2 Chengdu TECBOND Swine Influenza Vaccines Product Portfolios and Specifications
13.1.3 Chengdu TECBOND Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Chengdu TECBOND Main Business Overview
13.1.5 Chengdu TECBOND Latest Developments
13.2 Green Cross Veterinary
13.2.1 Green Cross Veterinary Company Information
13.2.2 Green Cross Veterinary Swine Influenza Vaccines Product Portfolios and Specifications
13.2.3 Green Cross Veterinary Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Green Cross Veterinary Main Business Overview
13.2.5 Green Cross Veterinary Latest Developments
13.3 Hipra
13.3.1 Hipra Company Information
13.3.2 Hipra Swine Influenza Vaccines Product Portfolios and Specifications
13.3.3 Hipra Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Hipra Main Business Overview
13.3.5 Hipra Latest Developments
13.4 MSD Animal Health (Merck)
13.4.1 MSD Animal Health (Merck) Company Information
13.4.2 MSD Animal Health (Merck) Swine Influenza Vaccines Product Portfolios and Specifications
13.4.3 MSD Animal Health (Merck) Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 MSD Animal Health (Merck) Main Business Overview
13.4.5 MSD Animal Health (Merck) Latest Developments
13.5 Zoetis
13.5.1 Zoetis Company Information
13.5.2 Zoetis Swine Influenza Vaccines Product Portfolios and Specifications
13.5.3 Zoetis Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Zoetis Main Business Overview
13.5.5 Zoetis Latest Developments
13.6 CAHIC
13.6.1 CAHIC Company Information
13.6.2 CAHIC Swine Influenza Vaccines Product Portfolios and Specifications
13.6.3 CAHIC Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 CAHIC Main Business Overview
13.6.5 CAHIC Latest Developments
13.7 Boehringer Ingelheim
13.7.1 Boehringer Ingelheim Company Information
13.7.2 Boehringer Ingelheim Swine Influenza Vaccines Product Portfolios and Specifications
13.7.3 Boehringer Ingelheim Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Boehringer Ingelheim Main Business Overview
13.7.5 Boehringer Ingelheim Latest Developments
13.8 Ceva
13.8.1 Ceva Company Information
13.8.2 Ceva Swine Influenza Vaccines Product Portfolios and Specifications
13.8.3 Ceva Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Ceva Main Business Overview
13.8.5 Ceva Latest Developments
13.9 Ringpu Biology
13.9.1 Ringpu Biology Company Information
13.9.2 Ringpu Biology Swine Influenza Vaccines Product Portfolios and Specifications
13.9.3 Ringpu Biology Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Ringpu Biology Main Business Overview
13.9.5 Ringpu Biology Latest Developments
13.10 DHN
13.10.1 DHN Company Information
13.10.2 DHN Swine Influenza Vaccines Product Portfolios and Specifications
13.10.3 DHN Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 DHN Main Business Overview
13.10.5 DHN Latest Developments
14 Research Findings and Conclusion
*If Applicable.